Portola Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch PTLA and buy or sell other stocks, ETFs, and their options commission-free!

About PTLA

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke.

CEO

J. Scott Garland, MBA

CEOJ. Scott Garland, MBA

Employees

—

Employees—

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2003

Founded2003

Employees

—

Employees—

PTLA Key Statistics

Market cap

1.42B

Market cap1.42B

Price-Earnings ratio

-4.78

Price-Earnings ratio-4.78

Dividend yield

—

Dividend yield—

Average volume

2.32M

Average volume2.32M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$31.73

52 Week high$31.73

52 Week low

$5.31

52 Week low$5.31